1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Addictions Therapeutics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Addictions Therapeutics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising prevalence of addiction disorders
- 5.1.2 Increased focus on mental health
- 5.1.3 Growth in personalized therapies
5.2 Market Opportunities
- 5.2.1 Innovative treatment methods emerging
- 5.2.2 Increasing awareness on addiction care
- 5.2.3 Government initiatives for addiction care
5.3 Future Trends
- 5.3.1 Personalized addiction treatment focus
- 5.3.2 Expansion of digital therapy solutions
- 5.3.3 Increased telemedicine applications
5.4 Impact of Drivers and Restraints
6. North America Addictions Therapeutics Market Regional Analysis
6.1 North America Addictions Therapeutics Market Overview
6.2 North America Addictions Therapeutics Market Revenue 2017-2027 (US$ Million)
6.3 North America Addictions Therapeutics Market Forecast Analysis
7. North America Addictions Therapeutics Market Analysis – by Treatment Type
7.1 Nicotine Addiction Treatment
- 7.1.1 Overview
- 7.1.2 Nicotine Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Alcohol Addiction Treatment
- 7.2.1 Overview
- 7.2.2 Alcohol Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Opioid Addiction Treatment
- 7.3.1 Overview
- 7.3.2 Opioid Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Other Substance Addiction Treatment
- 7.4.1 Overview
- 7.4.2 Other Substance Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Addictions Therapeutics Market Analysis – by Drug Type
8.1 Varenicline
- 8.1.1 Overview
- 8.1.2 Varenicline: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Bupropion
- 8.2.1 Overview
- 8.2.2 Bupropion: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Nicotine Replacement Products
- 8.3.1 Overview
- 8.3.2 Nicotine Replacement Products: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Buprenorphine
- 8.4.1 Overview
- 8.4.2 Buprenorphine: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Naltrexone
- 8.5.1 Overview
- 8.5.2 Naltrexone: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Disulfiram
- 8.6.1 Overview
- 8.6.2 Disulfiram: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Addictions Therapeutics Market Analysis – by Treatment Center
9.1 Outpatient Treatment Center
- 9.1.1 Overview
- 9.1.2 Disulfiram: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Residential Treatment Center
- 9.2.1 Overview
- 9.2.2 Disulfiram: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Inpatient Treatment Center
- 9.3.1 Overview
- 9.3.2 Disulfiram: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Addictions Therapeutics Market – North America Analysis
10.1 North America
- 10.1.1 North America Addictions Therapeutics Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Addictions Therapeutics Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Addictions Therapeutics Market Breakdown, by Treatment Type
- 10.1.1.1.2 US: North America Addictions Therapeutics Market Breakdown, by Drug Type
- 10.1.1.1.3 US: North America Addictions Therapeutics Market Breakdown, by Treatment Center
- 10.1.1.2 Canada:
North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Addictions Therapeutics Market Breakdown, by Treatment Type
- 10.1.1.2.2 Canada: North America Addictions Therapeutics Market Breakdown, by Drug Type
- 10.1.1.2.3 Canada: North America Addictions Therapeutics Market Breakdown, by Treatment Center
- 10.1.1.3 Mexico :
North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Addictions Therapeutics Market Breakdown, by Treatment Type
- 10.1.1.3.2 Mexico : North America Addictions Therapeutics Market Breakdown, by Drug Type
- 10.1.1.3.3 Mexico : North America Addictions Therapeutics Market Breakdown, by Treatment Center
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Addictions Therapeutics Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Indivior PLC
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Pfizer Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GlaxoSmithKline plc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bausch Health Companies Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Cipla Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Orexo AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 PurduePharma L.P
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Alvogen
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Camurus AB
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Hikma Pharmaceuticals PLC
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Addictions Therapeutics Market
